Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Markel, Gal"'
Autor:
Gilboa S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Pras Y; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mataraso A; Sheba Medical Center, Tel Hashomer, Israel., Bomze D; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Markel G; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel. Electronic address: markel@tauex.tau.ac.il., Meirson T; Shamir Medical Center (Assaf Harofeh), Rishon Lezion, Israel; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Israel. Electronic address: Tomermrsn@gmail.com.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Aug; Vol. 153, pp. 190-202. Date of Electronic Publication: 2021 Jun 26.
Autor:
Bar J; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel. Electronic address: Bar.jair@gmail.com., Markel G; Sackler Faculty of Medicine, Tel Aviv University, Israel; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel., Gottfried T; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Percik R; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel; Institute of Endocrinology, Sheba Medical Center, Israel., Leibowitz-Amit R; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel., Berger R; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel., Golan T; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel., Daher S; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Taliansky A; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Dudnik E; Thoracic Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Israel., Shulman K; Hillel Yaffe Medical Center, Hadera, Israel., Urban D; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel., Onn A; Pulmonology Institute, Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Oct; Vol. 120, pp. 122-131. Date of Electronic Publication: 2019 Sep 10.
Autor:
Ben-Betzalel G; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel. Electronic address: Guy.Ben-Betzalel@sheba.health.gov.il., Steinberg-Silman Y; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel., Stoff R; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel., Asher N; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel., Shapira-Frommer R; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel., Schachter J; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel., Markel G; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel-HaShomer, Israel; Department of Clinical Immunology and Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Israel. Electronic address: Gal.markel@sheba.health.gov.il.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Feb; Vol. 108, pp. 61-68. Date of Electronic Publication: 2019 Jan 14.
Autor:
Ben-Betzalel G; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: Guy.ben-betzalel@sheba.health.gov.il., Baruch EN; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel., Boursi B; Division of Oncology, Sheba Medical Center, Ramat-Gan, Israel., Steinberg-Silman Y; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel., Asher N; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel., Shapira-Frommer R; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel., Schachter J; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Oncology, Sackler Faculty of Medicine, Tel Aviv University, Israel., Markel G; Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Sep; Vol. 101, pp. 229-235. Date of Electronic Publication: 2018 Aug 07.